HFCL Limited (HFCL)
Investor Presentation
Investor Presentation - Q2FY27
- Revenue 2,542 Cr +144% y-y; EBITDA 658 Cr (margin 25.9%, +640 bps y-y); PAT 394 Cr (margin 15.5%, +860 bps y-y)
- FY27 revenue growth expected at least 80%, aiming for ₹10,000 Cr revenue earlier than FY29
- Order book strong at ₹28,911 Cr with robust pipeline supporting 6-7 years growth
- Defence revenue targeted at ₹500 Cr in FY27; strategic options under review for business focus
- Capex of ₹1,800 Cr planned for optical fibre, cable, and preform capacity expansion
- EBITDA margin expected to expand from ~16.7% in FY26 to >27% by FY29
- Exports target >70% revenue by FY27; product revenue to reach ~90%
- Private sector revenue now 92%, shifting from government contracts
- Manufacturing capacity expansions underway with 6 facilities and 3 R&D centers
- MD: "Moving ahead with conviction to convert opportunities into sustained growth and shareholder value"
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 HFCL — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add HFCL to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on HFCL Limited
Important.
The summary above is generated automatically from HFCL Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.